OncoRes Medical has announced it will receive new funding to support the clinical development of the Elora device, a tool aimed at improving breast surgery procedures. The funding is expected to help advance the technology behind the Elora device, supporting further research and testing in clinical settings.
The Elora device has been designed to give surgeons better real-time feedback during breast surgery. This technology can help doctors distinguish healthy tissue from abnormal tissue more accurately, which may lead to safer operations and better recovery for patients.
With the additional funding, OncoRes Medical plans to keep working closely with hospitals and research teams while developing the Elora device. The company hopes this support will speed up the process of bringing the device to operating rooms and make it available to more patients who need breast surgery.
The improvement and testing of devices like Elora show the ongoing innovation in breast surgery. Experts believe that advances in technology can help raise overall surgical standards, reduce mistakes, and help patients heal faster after operations.
The investment in the Elora device reflects a broader trend in medical technology, where new approaches are being developed to improve patient outcomes. OncoRes Medical’s work highlights the continuing progress in the field of breast surgery.
